Literature DB >> 6607283

In vivo effects of antibodies against a high frequency idiotype of anti-DNA antibodies in MRL mice.

D Teitelbaum, J Rauch, B D Stollar, R S Schwartz.   

Abstract

The in vivo effects of a rabbit antiserum against the dominant idiotype of MRL-lpr/lpr anti-DNA antibodies (termed H130) were studied in MRL-lpr/lpr, MRL/++, and BALB/c mice. Under the conditions we examined, the anti-idiotype did not suppress anti-DNA antibodies or the H130 idiotype in either MRL-lpr/lpr or MRL/++ mice. By contrast, MRL/++ and BALB/c mice responded to the antiserum by producing antibodies with the H130 idiotype. The increase in levels of the idiotype was accompanied by a rise in anti-DNA antibodies only when F(ab')2 fragments of the rabbit antiserum were administered. Only about 10% of the induced H130+ immunoglobulins were anti-DNA antibodies. An immunoregulatory disturbance in MRL-lpr/lpr mice may account for their resistance to anti-idiotypic antibodies. Treatment of autoimmune diseases with anti-idiotypes may have the undesired effect of augmenting the production of autoantibodies.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6607283

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Specificity and cross-reactive idiotypes of anti-gp330 autoantibodies in active Heymann nephritis.

Authors:  R J Specht Grijp-Glandorf; E De Heer; C C Dekker-Nooren; M R Daha; L A Van Es
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

Review 2.  Origins of anti-DNA autoantibodies.

Authors:  R S Schwartz; B D Stollar
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

3.  Experimental autoimmune uveoretinitis: idiotypic regulation and disease suppression.

Authors:  Y De Kozak; M Mirshahi
Journal:  Int Ophthalmol       Date:  1990-01       Impact factor: 2.031

4.  An idiotope-specific autoantibody in SLE.

Authors:  C G Mackworth-Young; R S Schwartz
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

5.  Binding specificity of antiidiotypic autoantibodies to anti-DNA antibodies in humans.

Authors:  T Sasaki; T Muryoi; O Takai; E Tamate; H Saito; K Yoshinaga
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

6.  Suppression of experimental systemic lupus erythematosus (SLE) with specific anti-idiotypic antibody-saporin conjugate.

Authors:  M Blank; J Manosroi; Y Tomer; A Manosroi; J Kopolovic; S Charcon-Polak; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

7.  Detection of cross-reactive anti-DNA antibody idiotypes on renal tissue-bound immunoglobulins from lupus patients.

Authors:  D A Isenberg; C Collins
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

8.  Anti-idiotype and immunosuppressant treatment of murine lupus.

Authors:  C Morland; J Michael; D Adu; T Kizaki; A J Howie; A Morgan; N A Staines
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

9.  Selective elimination of anti-DNA antibody-producing cells by antiidiotypic antibody conjugated with neocarzinostatin.

Authors:  T Sasaki; T Muryoi; O Takai; E Tamate; Y Ono; Y Koide; N Ishida; K Yoshinaga
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

10.  Suppression of anti-DNA antibody production in MRL mice by treatment with anti-idiotypic antibodies.

Authors:  W Mahana; B Guilbert; S Avrameas
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.